The Intersection of Healthcare and AI

From detecting early signs of disease to streamlining administrative tasks, artificial intelligence is reshaping how medical professionals deliver treatment and interact with patients.
At the 43rd annual J.P. Morgan Healthcare Conference in San Francisco, UCLA Anderson and the UCLA Technology Development Group presented a panel highlighting the intersection of innovation, entrepreneurship, and investment to shed light on the trajectory of AI in healthcare and the challenges of scaling successful solutions to a global market. It was Anderson’s third annual event focused on healthcare.
Three panelists with a wealth of experience in the healthcare space explored the transformative potential of AI in healthcare. The discussion included a front-line perspective on how AI is already making strides in diagnostics, patient care and personalized medicine. Panelists highlighted both the benefits and challenges of integrating AI into medical practice, including the need for rigorous validation and ethical considerations in deploying new technologies.
Panelists shared insights into innovative products and solutions, illustrating how AI is enabling new healthcare business models and driving efficiencies in the system. From predictive analytics to AI-powered drug discovery, these advancements have the potential to drastically reduce costs and improve outcomes. The panel also provided a macro view of the investment landscape, discussing the exciting opportunities and risks in funding AI healthcare startups.
Panel:
Dr. Nasim Afsar (’17), Former Chief Health Officer, Oracle
Dr. Ira Hofer, Co-Founder and President, Extrico Health
Jay Goss (B.A. ’91), General Partner, Wavemaker Three-Sixty Health
Moderator: Terry Kramer, Faculty Director, UCLA Anderson Easton Technology Management Center
Learn more about Healthcare@Anderson:
www.anderson.u...
#genAI #bioethics #medtech